Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 461-480

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Wenwen He Venture Capital at AbbVie	United States	Corporate VC	Healthcare		View profile
Ed Moss Vice President, Financial Advisor at Morgan Stanley	Washington, United States	Corporate VCPrivate equity	FinTechHardware		View profile
Kwamena A. Co-Founder at PAVE Investments	Sydney, Australia	Family OfficeVenture capital	AICommerce		View profile
Sebastian Huayamares Healthcare Associate at RA Capital Management	New York City, United States	Private equityVenture capital	AIFinTech		View profile
Pierre Paffenhoff Climate Tech Venture Capital - Investment Director at Fonds de solidarité FTQ	Montreal, Canada	Private equityVenture capital	AIClimate		View profile
Hilde Deleye Investor at Agentschap Innoveren & Ondernemen	Belgium	Government-backed	AIClimate		View profile
Lorine S. Strategic Advisor / Angel Investor at Morgan Stanley	United Kingdom	Corporate VCPrivate equity	FinTechHardware		View profile
Willem van Holthe Investor at Innovationquarter	The Hague, Netherlands	Government-backed	AIClimate		View profile
Isabella Canêo Venture Partner at Bayer	São Paulo, Brazil	Corporate VC	ClimateFood		View profile
Gülsüm Önder Investor at Domino Ventures	Bochum, Germany	Venture capital	AIClimate		View profile
Qiyuan Dou 澜亭资本 at Lanting Capital	Los Angeles, United States	Venture capital	HardwareHealthcare		View profile
Divum Raval Investment Analyst at Morgan Stanley	United States	Corporate VCPrivate equity	FinTechHardware		View profile
Hélène Poirier Investor at Deca-bfc	Dijon, France	AcceleratorGovernment-backed	ClimateFood		View profile
Benedicte Magerand Investor at Deca-bfc	Dijon, France	AcceleratorGovernment-backed	ClimateFood		View profile
Ryota Hasegawa Venture capitalist at SBI Investment	Tokyo, Japan	Private equityVenture capital	AIHardware		View profile
Angela Lam Investor at OMERS	Toronto, Canada	Government-backed	AIClimate		View profile
Pierre Balard Investor at Wellcome Trust	London, United Kingdom	Government-backed	AIHealthcare		View profile
Chi Wai Lee Morningside Technology Advisory LLC at Morningside	New York, United States	Private equityVenture capital	AIFinTech		View profile
Adam Luo Investor at Wuxi Biologics	Alexandria, United States	Corporate VC	Healthcare		View profile
Johann Krämer Founder in residence at Entrepreneurs First	London, United Kingdom	AcceleratorVenture capital	AIHardware		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal